RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...
Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus ALIF blades. The Cohere space is the first porous ...
StockStory.org on MSN1d
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs PeersLooking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...
Hosted on MSN20d
Globus Medical’s (NYSE:GMED) Q4 Sales Beat EstimatesMedical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 billion ...
Globus Medical GMED has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.81%. Currently, Globus Medical has a market ...
OsteoCentric Technologies has entered into a non-exclusive licensing agreement with Globus Medical. OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the ...
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to ...
StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...
OsteoCentric Technologies, a global leader in innovative medical technologies, announced it has entered into a non-exclusive ...
AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the ...
This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...
Net income rose by 77% to $26.5 million, highlighting significant growth. Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results